Shanghai Junshi Biosciences Co., Ltd.SSE: 688180

Announcement on 2024 Annual Profit Distribution Plan

Mar 28, 2025 · Issued by Shanghai Junshi Biosciences Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · Mar 28, 2025

On 6ix: 6ix.com/news/announcement-on-2024-annual-profit-distribution-plan-68

Announcement on 2024 Annual Profit Distribution Plan

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

6ix hasn’t read this filing yet.

Shanghai Junshi Biosciences Co., Ltd. on 6ix

Earlier from Shanghai Junshi Biosciences

Junshi Biosciences Announces Toripalimab’s Approval in SingaporeMar 26, 2025
Junshi Biosciences Announces Approval of sNDA for Toripalimab in Combination with Bevacizumab for 1st-line Treatment of Advanced Hepatocellular CarcinomaMar 23, 2025

Later from Shanghai Junshi Biosciences

Junshi Biosciences Announces 2024 Full Year Financial Results and Provides Corporate UpdatesMar 28, 2025
Announcement on Share Increase Plan for Controlling Shareholder, One of Actual Controllers and ChairmanApr 12, 2025
Junshi Biosciences Announces the sNDA Approval of Toripalimab for the 1st-line Treatment of MelanomaApr 25, 2025
Junshi Biosciences Announces Ongericimab’s sNDA Approval in ChinaMay 27, 2025
Announcement on Sub-project Change and Amount Adjustment of Some Investment Projects Financed by Raised FundsMay 30, 2025

All Shanghai Junshi Biosciences news releases

Follow Shanghai Junshi Biosciences into a list and get an email when it puts out news.

Follow Shanghai Junshi Biosciences